jake66

jake66

Good play on a speculative migraine pain management device. Around 600 M shares outstanding with low float and virtually no debt. A small investment in $ADHC could yield exponential returns in a few short years. Market cap could exceed to over $1B+ with successful FDA and clinical studies then successful marketplace execution. Over $1 PPS is not unreasonable...

jake66 Updated 

Possible swing trade idea on good news, TP 1: .40 TP 2: .59 Hoping to see strong volume on open.

jake66

Long term goal north of $3.00 (End 2018- mid 2019) List of (Possible) events to put this stock into the big leagues and big pharma 1) Flag ship product ATB 436 is now 1 clinical study away from being marketed to the public: - Antibe was formed to develop safer meds for pain and inflammation with Hydrogen Sulfide tech - Product ATB 436 was advanced into Phase 2...

jake66

Q1 Report was very solid however, I believe a retest back down to support is very possible. On Q1 release price was unable to break new highs causing a double top and suggesting price retracement. Also FCA is legging on EV tech, which could come to hurt them in 2018.

jake66 Updated 

Price target .25-.50 Market cap will explode. URA conference coming up at the end of may. ED procedure already being adopted at big practices with top doctors. Many more products in the pipeline with massive upside potential in multi billion dollar markets not to mention M&A in big pharma. Will continue to add.

jake66 Updated 

I am looking to hold this OTC stock for a few weeks till the end of the year. $LDSR is gaining ground before the RSA conference with a new partner announced this week. $LDSR offers award winning GDPR Compliance, Data Classification and Governance (ClassiDocs product) As GDPR comes into full effect I suspect many euro and U.S companies will partner with $LDSR....

jake66

Perfect head and shoulders formed. Waiting for a small retest @ the neck line then its all down hill from here. Target $150. Add in global iPhone demand slowing, as well as iPhone X being cancelled and this could sink even further.

jake66 Updated 

Long term goal: 1.00 CBD dog drops + treats, as well as pet oral CBD spray. Q1 over 10M in sales, hoping for more big multi million dollar contracts for this year in this super trendy Marijauna health market. Extreme upside potential for 2018.

jake66

Short down to $10

jake66

Double top could lead to possible 5 impulse waves. Weak model 3 sales and/or problems meeting production could also drive it lower. Drastically decreasing model s and model x demand.

jake66

"Budget" airline offering alternative to Aircanada or Westjet. Based out of a weird airport. Short down to .40

jake66

Trend contunination triangle. Huge market for lithium, with the up pace of electric cars being the driver.

jake66

Possible start of wave 3 after this massive impulse wave. Target, 1.80

jake66

With trump's uncertainty, people will be playing JPY and it's conservative outlook.

jake66

Inverse head and shoulders plus THC market heating up in Canada, both medical and recreational.

jake66

Here's a great buy opportunity if price breaks resistance on the 4hr. I will be monitoring the 86.80 level for a retest to enter.

jake66 Updated 

Tight stops on this great trade on EURAUD. TP 1: 1.4768 TP 2: 1.4861

jake66 Updated 

Simple heard and shoulder play, buying on the retrace! Pretty easy play here, SL below green support. TP: 115.500